Expression proteomics study to determine metallodrug targets and optimal drug combinations
Abstract The emerging technique termed functional identification of target by expression proteomics (FITExP) has been shown to identify the key protein targets of anti-cancer drugs. Here, we use this approach to elucidate the proteins involved in the mechanism of action of two ruthenium(II)-based an...
Guardado en:
Autores principales: | Ronald F. S. Lee, Alexey Chernobrovkin, Dorothea Rutishauser, Claire S. Allardyce, David Hacker, Kai Johnsson, Roman A. Zubarev, Paul J. Dyson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4de57fb3c86d42eab3c5f8158d0517a9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
por: Alexey L Chernobrovkin, et al.
Publicado: (2014) -
ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
por: Amir Ata Saei, et al.
Publicado: (2019) -
Proteome activity landscapes of tumor cell lines determine drug responses
por: Martin Frejno, et al.
Publicado: (2020) -
Combining LOPIT with differential ultracentrifugation for high-resolution spatial proteomics
por: Aikaterini Geladaki, et al.
Publicado: (2019) -
Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin
por: Pierre Sabatier, et al.
Publicado: (2021)